Abstract:Induced pluripotent stem cells (iPSC) that are generated from adult somatic cells are induced to express genes that make them pluripotent through reprogramming techniques, which may open up new possibilities for regenerative medicine to treat diseases in the future. Biotechnological, chemical, and physical modulation techniques are different reprogramming cell technologies to obtain iPSC and present their respective strengths in iPSC reprogramming‐based regenerative therapies, such as hair follicle defects, myocardial infarction, neurological disorders, liver diseases, and spinal cord injuries. Induced pluripotent stem cells (iPSCs) that are generated from adult somatic cells are induced to express genes that make them pluripotent through reprogramming techniques. With their unlimited proliferative capacity and multifaceted differentiation potential and circumventing the ethical problems encountered in the application of embryonic stem cells (ESC), iPSCs have a broad application in the fields of cell therapy, drug screening, and disease models and may open up new possibilities for regenerative medicine to treat diseases in the future. In this review, we begin with different reprogramming cell technologies to obtain iPSCs, including biotechnological, chemical, and physical modulation techniques, and present their respective strengths, and limitations, as well as the recent progress of research. Secondly, we review recent research advances in iPSC reprogramming‐based regenerative therapies. iPSCs are now widely used to study various clinical diseases of hair follicle defects, myocardial infarction, neurological disorders, liver diseases, and spinal cord injuries. This review focuses on the translational clinical research around iPSCs as well as their potential for growth in the medical field. Finally, we summarize the overall review and look at the potential future of iPSCs in the field of cell therapy as well as tissue regeneration engineering and possible problems. We believe that the advancing iPSC research will help drive long‐awaited breakthroughs in cellular therapy.

The Future of Ips Cells in Advancing Regenerative Medicine.

Inducing Pluripotency for Disease Modeling, Drug Development and Craniofacial Applications.

Application Potential of Induced Pluripotent Stem Cells in Cell Therapy for Stroke

Advances in Reprogramming of Peripheral Blood Cells to Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells As a Disease Modeling and Drug Screening Platform

Improving the Reprogramming Efficiency of Somatic Cells to Induced Pluripotent Stem Cells.

Induced Neural Stem/precursor Cells for Fundamental Studies and Potential Application in Neurodegenerative Diseases

[Progress and potential applications of induced pluripotent stem cell technology]

Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells

The Research Status of Induced Pluripotent Stem Cells

Generation and Application of Human Ips Cells

Reprogramming stem cells in regenerative medicine

Progress in the Reprogramming of Somatic Cells

Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells

Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications

The genomic stability of induced pluripotent stem cells

Progress and Bottleneck in Induced Pluripotency.

Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming

Clinical Grade iPS Cells: Need for Versatile Small Molecules and Optimal Cell Sources

Human Ips Cell-Based Therapy Considerations Before Clinical Applications

Technical advances of induced pluripotent stem cells